Decreased Expression of ARID1A Contributes to Infiltrative Growth of Esophageal Squamous Cell Carcinoma
-
- Ozawa Yohei
- Division of Advanced Surgical Science and Technology, Tohoku University Graduate School of Medicine Department of Pathology, Tohoku University Graduate School of Medicine
-
- Nakamura Yasuhiro
- Department of Pathology, Tohoku University Graduate School of Medicine
-
- Fujishima Fumiyoshi
- Department of Pathology, Tohoku University Hospital
-
- Felizola Saulo J.A.
- Department of Pathology, Tohoku University Graduate School of Medicine
-
- Takeda Kenichiro
- Department of Pathology, Tohoku University Graduate School of Medicine
-
- Okamoto Hiroshi
- Division of Advanced Surgical Science and Technology, Tohoku University Graduate School of Medicine
-
- Ito Ken
- Division of Advanced Surgical Science and Technology, Tohoku University Graduate School of Medicine Department of Pathology, Tohoku University Hospital
-
- Ishida Hirotaka
- Division of Advanced Surgical Science and Technology, Tohoku University Graduate School of Medicine Department of Pathology, Tohoku University Graduate School of Medicine
-
- Konno Takuro
- Division of Advanced Surgical Science and Technology, Tohoku University Graduate School of Medicine Department of Pathology, Tohoku University Hospital
-
- Kamei Takashi
- Division of Advanced Surgical Science and Technology, Tohoku University Graduate School of Medicine
-
- Ohuchi Noriaki
- Division of Advanced Surgical Science and Technology, Tohoku University Graduate School of Medicine
-
- Sasano Hironobu
- Department of Pathology, Tohoku University Graduate School of Medicine Department of Pathology, Tohoku University Hospital
この論文をさがす
抄録
The clinical outcome for esophageal squamous cell carcinoma (ESCC) patients is often poor because of the invasive nature of this tumor type. AT-rich interactive domain 1A (ARID1A) functions as a tumor suppressor, and its gene mutation has been reported in various human malignancies. ARID1A is a non-catalytic subunit of the SWItch/Sucrose Non Fermentable (SWI/SNF) chromatin-remodeling complex that regulates gene transcription. Decreased expression of ARID1A protein has been reported to decrease the expression of E-cadherin, an adhesion protein. However, the correlation between ARID1A and E-cadherin expression status in ESCC remains largely unknown. To address this issue, we examined the expression of ARID1A and E-cadherin in tumor specimens excised from 83 ESCC patients using immunohistochemical analysis. The intensity of the ARID1A immunoreactivity was significantly lower in tumors with a growth pattern characterized by ill-defined borders than that in tumors with an expansive growth pattern having a well-demarcated border or tumors with an intermediate growth pattern. Thus, decreased ARID1A immunoreactivity correlated with infiltrative growth of ESCC. In contrast, E-cadherin status did not correlate with the infiltrative growth pattern of ESCC. Moreover, ARID1A expression status did not significantly correlate with any of other clinicopathological factors, E-cadherin expression levels, or the clinical outcome of the patients. On the other hand, the patients with tumors expressing low levels of E-cadherin exhibited significantly lower survival rates than those with high expression. In conclusion, reduced ARID1A expression in tumor tissues contributes to infiltrative growth of ESCC, irrespective of E-cadherin expression levels.
収録刊行物
-
- The Tohoku Journal of Experimental Medicine
-
The Tohoku Journal of Experimental Medicine 235 (3), 185-191, 2015
東北ジャーナル刊行会
